Vident Investment Advisory, LLC Immunocore Holdings PLC Transaction History

Vident Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$46.12 - $65.71 $7,194 - $10,250	-156 Reduced 1.22%	12,624 $624,000
Q4 2022 Feb 14, 2023	SELL	$45.51 - $65.08 $371,771 - $531,638	-8,169 Reduced 38.99%	12,780 $729,000
Q3 2022 Nov 14, 2022	SELL	$37.34 - $57.44 $73,298 - $112,754	-1,963 Reduced 8.57%	20,949 $971,000
Q2 2022 Aug 15, 2022	SELL	$25.46 - $37.72 $353,868 - $524,270	-13,899 Reduced 37.76%	22,912 $854,000
Q1 2022 May 16, 2022	BUY	$18.94 - $34.29 $116,196 - $210,369	6,135 Added 20.0%	36,811 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$27.58 - $40.0 $846,044 - $1.23 Million	30,676 New	30,676 $1.05 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.